毕得医药 (688073.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(毕得医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 811,377,889.62532,207,309.99262,669,977.501,091,858,561.97805,006,735.83522,625,316.59252,455,900.29
 营业收入(元) 811,377,889.62532,207,309.99262,669,977.501,091,858,561.97805,006,735.83522,625,316.59252,455,900.29
二、营业总成本(元) 696,947,815.87456,333,477.22225,411,993.32940,546,450.07654,533,379.99409,834,164.70203,401,460.75
 营业成本(元) 477,309,328.92321,954,244.55160,517,623.25655,120,131.68481,152,783.89309,803,101.12142,431,418.90
 研发费用(元) 45,523,716.1930,050,598.6815,420,297.3563,227,409.3041,143,681.3026,776,177.2016,163,087.87
 营业税金及附加(元) 4,100,758.522,441,504.241,025,276.595,137,913.722,787,154.162,136,669.90319,578.37
 销售费用(元) 94,315,547.6860,635,280.1931,440,807.65127,062,863.2288,537,705.6555,694,900.1025,934,576.21
 管理费用(元) 81,024,454.7253,230,049.8424,653,471.92119,550,943.4571,350,081.4144,022,128.0521,229,375.58
 财务费用(元) -5,325,990.16-11,978,200.28-7,645,483.44-29,552,811.30-30,438,026.42-28,598,811.67-2,676,576.18
  其中:利息费用(元) 4,231,686.973,404,174.98856,539.192,530,435.161,593,602.711,018,054.41432,571.52
  其中:利息收入(元) 18,154,660.6113,385,141.737,322,689.0427,983,759.5421,261,484.3714,415,968.927,363,343.86
三、其他经营收益
 加:公允价值变动收益(元) 1,269,450.80-323,502.63-1,221,398.52-12,632,140.39-14,119,146.13-12,327,068.23-516,592.66
 加:投资收益(元) 1,509,336.60967,790.34435,243.403,759,981.222,879,320.641,091,146.8141,576.37
 资产处置收益(元) 833,396.64610,649.76432,182.38438,709.58115,253.3982,880.04-
 资产减值损失(元) -21,223,248.36-12,421,528.51-6,931,767.23-18,263,044.45-8,595,753.10-3,966,774.79-2,300,165.25
 信用减值损失(元) -3,619,264.95-2,616,286.74-330,959.49-4,994,469.72-4,607,320.98-3,792,300.66-2,790,710.87
 其他收益(元) 9,087,820.691,983,839.661,546,551.467,008,019.036,219,430.804,128,717.99156,391.02
四、营业利润(元) 102,287,565.1764,074,794.6531,187,836.18126,629,167.17132,365,140.4698,007,753.0543,644,938.15
 加:营业外收入(元) 334,774.76197,043.79136,932.4459,847.02237,403.1813,516.9610,343.58
 减:营业外支出(元) 230,780.1417,670.8814,538.18692,242.81671,823.20578,532.23384,427.31
五、利润总额(元) 102,391,559.7964,254,167.5631,310,230.44125,996,771.38131,930,720.4497,442,737.7843,270,854.42
 减:所得税费用(元) 18,537,666.9912,415,103.015,235,287.4417,550,472.6019,283,090.8213,859,710.426,342,614.23
六、净利润(元) 83,853,892.8051,839,064.5526,074,943.00108,446,298.78112,647,629.6283,583,027.3636,928,240.19
(一)按经营持续性分类
  持续经营净利润(元) 83,853,892.8051,839,064.5526,074,943.00108,446,298.78112,647,629.6283,583,027.3636,928,240.19
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 83,853,892.8051,839,064.5526,074,943.00109,571,788.68113,398,686.4683,810,379.1536,928,240.19
  少数股东损益(元) ----1,125,489.90-751,056.84-227,351.79-
 扣除非经常性损益后的净利润(元) 72,390,382.5048,256,312.1325,431,195.19122,510,054.55121,008,118.5591,865,210.0638,966,750.90
七、每股收益
 一、基本每股收益(元) 0.940.580.291.211.250.920.57
 二、稀释每股收益(元) 0.940.580.291.211.250.920.57
八、其他综合收益(元) 3,372,706.74376,362.85-339,064.78282,987.35-8,619,012.01-19,177,951.89-14,098,118.88
 归属于母公司股东的其他综合收益(元) 3,372,706.74376,362.85-339,064.78282,987.35-8,619,012.01-19,177,951.89-14,098,118.88
九、综合收益总额(元) 87,226,599.5452,215,427.4025,735,878.22108,729,286.13104,028,617.6164,405,075.4722,830,121.31
 归属于母公司所有者的综合收益总额(元) 87,226,599.5452,215,427.4025,735,878.22109,854,776.03104,779,674.4564,632,427.2622,830,121.31
 归属于少数股东的综合收益总额(元) ----1,125,489.90-751,056.84-227,351.79-
公告日期 2024-10-242024-08-292024-04-262024-04-262023-10-282023-08-312023-04-20
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院